CEFAZOLIN SODIUM

The U.S. FDA approved Cefazolin sodium for the treatment of bacterial infections on March 18, 1981. Cefazolin sodium is an antibiotic containing the active ingredient cefazolin sodium. It is classified as a cephalosporin.

Cefazolin sodium is used to treat infections in different body parts, such as skin, joints, and bones, caused by bacteria. These antibiotics work by killing the bacteria that are causing your infection.

A healthcare professional will administer cefazolin sodium in a hospital setting. It is usually administered via different routes, including intravenous infusion (drip), slow injection into a vein, or deep injection into a large muscle. Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.

The most common side effects of Cefazolin sodium are nausea or vomiting, diarrhea, injection site reactions (swelling, pain, redness), oral or vaginal infection, and loss of appetite. Serious side effects while taking Cefazolin sodium are abdominal or stomach cramps, fever, allergic reaction (swelling in the face, lips, or tongue, skin rash, itching, or hives), shortness of breath, unusual bleeding or bruising, and frequent infections (severe chills, mouth ulcers).

Cefazolin sodium should not be taken if you have allergies to Cefazolin sodium, other cephalosporin antibacterial drugs, penicillins, other beta-lactam drugs, or any of the medication's ingredients. It is not recommended for premature infants or infants under one month of age. The safety of this medication in such cases has not been established. Patients with kidney disease should consume this medicine cautiously. Notify your doctor if you are pregnant, planning to get pregnant, or think you may be pregnant or breastfeeding because it may be unsafe to use this medicine during pregnancy and breastfeeding.

Before taking Cefazolin sodium, inform your doctor if you have a history of intestinal disorders, particularly colitis (bowel inflammation), kidney problems, or if you are following a low sodium diet. It is unknown whether consuming alcohol can cause any harmful side effects or not. Consult your doctor for more information.

For patients with kidney impairment, a reduced dosage of Cefazolin Sodium may be prescribed, and a blood test will be arranged. Do not discontinue the medicine without your doctor's guidance. Do not take a double dose to compensate for a missed dose. Inform your doctor if you develop any serious side effects. Contact your doctor for additional information. Store out of reach of children and pets. Do not freeze. Do not store above 25°C. Always verify the expiry date before use.

K Ries et al; Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic; Antimicrobial agents and Chemotherapy; Published on Feb 1973; [Accessed on 22nd June 2023]; http://www.ncbi.nlm.nih.gov/pmc/articles/pmc444382/ B.Braun Medical Inc, US Food and Drug Administration, [Revised on Jan 2012] [ Accessed on 22nd June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050779s019lbl.pdf Sandoz Pty Ltd, Package information leaflet, [Published on July 2014] [Accessed on 22nd June 2023], https://www.nps.org.au/assets/medicines/01e3720f-62ad-4cc6-8f06-a53300ff19ec-reduced.pdf Package leaflet: Information for the patient, [Accessed on 22nd June 2023], https://file.wuxuwang.com/hma/DE_H_5116_001_FinalPI_2of3.pdf